# Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease

> **NCT02721472** · NA · COMPLETED · sponsor: **Theravia** · enrollment: 44 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **PROCEDURE:** micro- and macro-circulatory vascular remodelling measures not practice in routine care
- **PROCEDURE:** Biological measures not practice in routine care

## Key facts

- **NCT ID:** NCT02721472
- **Lead sponsor:** Theravia
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-17
- **Primary completion:** 2019-11-14
- **Final completion:** 2019-11-14
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02721472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02721472, "Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02721472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*